Browse medicines, page 19 of 37

Use listed on the medicine record

Fluorodopa F 18 Injection is indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations. Fluorodopa F 18 Injection is a radioactive diagnostic agent indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS).

Use listed on the medicine record

Use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy

Use listed on the medicine record

INDICATIONS & USAGE Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation.

Use listed on the medicine record

Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine Decanoate Injection, USP has not been shown effective in the management of behavioral complications in patients with mental retardation.

Use listed on the medicine record

The inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Use listed on the medicine record

Positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress

Use listed on the medicine record

Positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density

Use listed on the medicine record

Obsessive compulsive disorder

Use listed on the medicine record

CMV retinitis

Use listed on the medicine record

The risk of mortality

Use listed on the medicine record

CONTEPO is an epoxide antibacterial indicated for the treatment of patients 18 years of age and older with complicated urinary tract infections (cUTI) including acute pyelonephritis caused by susceptible isolates of Escherichia coli and Klebsiella pneumoniae . ( 1.1 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of CONTEPO and other antibacterial drugs, CONTEPO should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.

Use listed on the medicine record

AnubisMed 50+ Protection Fluid Indications and Usage

Use listed on the medicine record

LYTGOBI is indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements [see Dosage and Administration (2.1) ] . This indication is approved under accelerated approval based on overall response rate and duration of response [see Clinical Studies (14.1) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Use listed on the medicine record

Intravenous use

Use listed on the medicine record

AMBELVIST is indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system) AMBELVIST is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine,…

Use listed on the medicine record

Magnetic resonance imaging (MRI) to visualize

Use listed on the medicine record

Seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder

Use listed on the medicine record

、 Clean and dry the face 2、 Apply an appropriateamount of face cream evenly on the face 3、Gently massage until absorbed

Use listed on the medicine record

Gefitinib tablets are indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test [see Clinical Studies (14 ) ] . Limitation of Use: Safety and efficacy of gefitinib tablets have not been established in patients with metastatic NSCLC whose tumors have EGFR mutations other than exon 19 deletions or exon 21 (L858R) substitution mutations [see Clinical Studies (14) ] .

Use listed on the medicine record

Advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy

Use listed on the medicine record

Major depressive disorder

Use listed on the medicine record

Adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test

Use listed on the medicine record

The inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Use listed on the medicine record

▪ Helps relieve symptoms of fungal and inflammatory skin conditions, including: – Folliculitis – Dandruff – Seborrheic dermatitis – Tinea versicolor – Jock itch ▪ Reduces itching, flaking, redness, and irritation

Use listed on the medicine record

Spray directly onto closed eyelids or applyusing a sterile cotton pad Gently wipe acrossthe eyelid and lash line Use 1-2 times daily oras recommended by your eye care professional If you wear contact lenses, please removethem before use For external eyelid use only

Use listed on the medicine record

Severe frostbite

Use listed on the medicine record

The following serious infections caused by designated susceptible bacteria

Use listed on the medicine record

Symptoms of depression

Use listed on the medicine record

Iodixanol injection is indicated in for: Iodixanol injection is a radiographic contrast agent indicated for the following: Intra-arterial Procedures ( 1.1 ) Adults and pediatric patients 12 years of age and over Intra-arterial digital subtraction angiography (270 mg Iodine/mL and 320 mg Iodine/mL). Angiocardiography (left ventriculography and selective coronary arteriography), peripheral arteriography, visceral arteriography, and cerebral arteriography (320 mg Iodine/mL).

Use listed on the medicine record

IOMERVU is a radiographic contrast agent indicated for: Intra-arterial Procedures † ( 1.1 ) Cerebral arteriography, includingintra-arterial digital subtraction angiography (IA-DSA), in adults and pediatric patients Visceral and peripheral arteriography and aortography, including IA-DSA, in adults and pediatric patients Coronary arteriography and cardiac ventriculography in adults Radiographic evaluation of cardiac chambers and related arteries in pediatric patients Intravenous Procedures † ( 1.2 ) Computed tomography (CT) of the head and body in adults and pediatric patients CT angiography of…

Use listed on the medicine record

ISOVUE is a radiographic contrast agent indicated for: Intra-arterial Procedures † ( 1.1 ) Cerebral arteriography in adults Peripheral arteriography in adults Selective visceral arteriography and aortography in adults Coronary arteriography and cardiac ventriculography in adults Angiocardiography in pediatric patients Intravenous Procedures † ( 1.2 ) Excretory urography in adults and pediatric patients Computed tomography (CT) of head and body in adults and pediatric patients Peripheral venography in adults Oral Procedures † ( 1.3 ) CT of the abdomen and pelvis to delineate the…

Use listed on the medicine record

ULTRAVIST ® Injection is an iodinated contrast agent indicated for: ULTRAVIST is a radiographic contrast agent indicated for: Intra-Arterial Procedures † • Cerebral arteriography and peripheral arteriography in adults ( 1.1 ) • Coronary arteriography and left ventriculography, visceral angiography, and aortography in adults ( 1.1 ) • Radiographic evaluation of cardiac chambers and related arteries in pediatric patients aged 2 years and older ( 1.1 ) Intravenous Procedures † • Excretory urography in adults and pediatric patients aged 2 years and older ( 1.2 ) • Contrast computed tomography…

Use listed on the medicine record

OPTIRAY is indicated for: OPTIRAY is a radiographic contrast agent indicated for the following: Intra-arterial Procedures ( 1.1 ) Adults: Cerebral Arteriography (300, 320 mg iodine/mL) Peripheral Arteriography (300, 320, 350 mg iodine/mL ) Visceral and Renal Arteriography, Aortography (320 mg iodine/mL) Coronary Arteriography and Left Ventriculography (320, 350 mg iodine/mL) Pediatric Patients: Angiocardiography (320, 350 mg iodine/mL) Intravenous Procedures ( 1.2 ) Adults: Computed tomography (CT) Imaging of Head and Body (300, 320, 350 mg iodine/mL) Venography (300, 320, 350 mg iodine/mL)…

Use listed on the medicine record

Paroxysmal nocturnal hemoglobinuria

Use listed on the medicine record

INFeD is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron. INFeD, an iron replacement product, is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or an unsatisfactory response to oral iron. ( 1 )

Use listed on the medicine record

Iron deficiency anemia

Use listed on the medicine record

for preparation of skin prior to injectio. Apply the product to the skin, take the injection or puncture site as the center, slowly rotate from the inside to the outside, and gradually apply the product for two times. The disinfection area should be more than 5cm x 5cm, and the action time should be1 min. Please clean before disinfection.

Use listed on the medicine record

Isosulfan Blue Injection 1% upon subcutaneous administration, delineates the lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; lymph node response to therapeutic modalities ( 1.1 ). 1.1 Lymphatic Vessel Delineation Isosulfan Blue Injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection.

Use listed on the medicine record

IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated. Anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting.

Use listed on the medicine record

Pain

Use listed on the medicine record

For best results, follow these steps carefully:lukewarm water. 1.Wet hair and scalp thoroughly with 2.Applya sufficient amount of shampooto generate a rich lather.3.Gently massage the lather into your scalp and hair. 4.Leave the lather on the scalp for 3-5medication to work effectively.5.Rinse thoroughly with water. minutes. This contact time is crucialfor the

Use listed on the medicine record

Itchy eyes due to ragweed, pollen, grass, animal hair and dander

Use listed on the medicine record

Labetalol Hydrochloride is indicated in the management of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including beta adrenergic blockers.

Use listed on the medicine record

Directions Wash and dry affected area, apply a thin layer of LMNOOP over affected area, gently massage until fully absorbed, repeat 2-3 times daily.

Use listed on the medicine record

Lapatinib tablets are indicated in combination with: capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2) and who have received prior therapy, including an anthracycline, a taxane, and trastuzumab. Limitations of Use : Patients should have disease progression on trastuzumab prior to initiation of treatment with lapatinib tablets in combination with capecitabine.

Use listed on the medicine record

Intraocular pressure

Use listed on the medicine record

Regul Oil Cleansing Cream indications